HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$4.16
Day range
$3.99 - $4.40
Year range
$2.32 - $5.40
Market cap
241.32M USD
Avg Volume
1.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.73M | 70.55% |
Net income | -11.22M | 75.02% |
Net profit margin | — | — |
Earnings per share | -0.13 | 87.74% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.57M | 28.66% |
Total assets | 144.91M | 20.27% |
Total liabilities | 38.88M | -69.86% |
Total equity | 106.03M | — |
Shares outstanding | 60.00M | — |
Price to book | 2.35 | — |
Return on assets | -40.38% | — |
Return on capital | -55.63% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.22M | 75.02% |
Cash from operations | -17.71M | -127.85% |
Cash from investing | 14.96M | 175.12% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.76M | -113.52% |
Free cash flow | -9.24M | -241.68% |
About
Founded
2004
Headquarters
Website
Employees
31
